"...The pharmaceutical company said it would also plead guilty to a federal criminal charge concerning a payment to a managed care customer. Federal law requires drugmakers to give their lowest prices to Medicaid, but a group of whistle-blowers accused the company of giving some private health care providers better deals on its drugs by offering them under-the-table "patient education" grants."